<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39553423</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2674-1199</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in epidemiology</Title><ISOAbbreviation>Front Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Evaluating health-related quality of life in Ethiopia: systematic review and meta-analysis of EQ-5D-based studies.</ArticleTitle><Pagination><StartPage>1455822</StartPage><MedlinePgn>1455822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1455822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fepid.2024.1455822</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Health-related quality of life (HRQoL) is crucial for understanding how health conditions impact overall well-being. The EuroQol-5 Dimension (EQ-5D) is a widely used tool for measuring HRQoL across diseases. In Ethiopia, this tool has been employed to assess HRQoL across various healthcare settings. This study aims to summarize EQ-5D-derived health outcomes in Ethiopian populations and identify key determinants influencing these outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic search of PubMed, Embase, and Scopus was conducted through May 2024, with no publication date restrictions, focusing on HRQoL and EQ-5D instruments in Ethiopian populations. Grey literature searches were also performed using Google's Advanced Search. Cross-sectional studies across various diseases were included. Data were extracted by two independent reviewers, and pooled mean EQ-5D utility and EQ-5D visual analog scale (EQ-VAS) scores were calculated using a random-effects model in STATA software version 17. Study quality was evaluated using the Agency for Healthcare Research and Quality (AHRQ) checklist, and heterogeneity was assessed using the <i>I</i>² statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fourteen cross-sectional studies involving 5,639 patients from 2019 to 2024 in Ethiopia were analyzed. Health utility values varied across diseases, with pain/discomfort and anxiety/depression being the most commonly affected dimensions. The pooled EQ-5D utility for HIV patients was 0.88, and the EQ-VAS score was 76.59. For diabetes mellitus (DM) patients, the pooled utility was 0.78, and the EQ-VAS score was 69.36. For COVID-19 patients, the pooled utility was 0.86, and the EQ-VAS score was 74.56. Cancer patients had a pooled EQ-VAS score of 67.87.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The EQ-5D is a reliable tool for measuring HRQoL in Ethiopian patients across various diseases. The study's pooled EQ-5D scores provide valuable insights for future economic evaluations in the Ethiopian healthcare system.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://doi.org/10.1136/bmjopen-2024-085354, PROSPERO (CRD42024505028).</AbstractText><CopyrightInformation>© 2024 Tarekegn, Gebrie, Kassaw, Dagne Taye, Girmaw and Ashagrie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarekegn</LastName><ForeName>Tenaw Baye</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Woldia University, Woldia, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebrie</LastName><ForeName>Desye</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Woldia University, Woldia, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassaw</LastName><ForeName>Abebe Tarekegn</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Woldia University, Woldia, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagne Taye</LastName><ForeName>Abebe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Debre Markos University, Debre Markos, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girmaw</LastName><ForeName>Fentaw</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Woldia University, Woldia, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashagrie</LastName><ForeName>Getachew</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, College of Health Science, Woldia University, Woldia, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Epidemiol</MedlineTA><NlmUniqueID>9918419158106676</NlmUniqueID><ISSNLinking>2674-1199</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EQ-5D</Keyword><Keyword MajorTopicYN="N">Ethiopia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39553423</ArticleId><ArticleId IdType="pmc">PMC11563791</ArticleId><ArticleId IdType="doi">10.3389/fepid.2024.1455822</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. (2016) 34:645–9. 10.1007/s40273-016-0389-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-016-0389-9</ArticleId><ArticleId IdType="pubmed">26892973</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilou P. Quality of life: definition and measurement. Eur J Psychol. (2013) 9(1):150–62. 10.5964/ejop.v9i1.337</Citation><ArticleIdList><ArticleId IdType="doi">10.5964/ejop.v9i1.337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med. (1995) 41(10):1383–94. 10.1016/0277-9536(95)00116-O</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0277-9536(95)00116-O</ArticleId><ArticleId IdType="pubmed">8560306</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan L, Hu H, Li SC. Mapping utility scores from the HeartQoL questionnaire into the EQ-5D for ischemic heart disease. Value Health Reg Issues. (2021) 24:33–7. 10.1016/j.vhri.2020.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vhri.2020.02.001</ArticleId><ArticleId IdType="pubmed">33486460</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier J, Ara R, Rowen D, Chevrou-Severac H. A review of generic preference-based measures for use in cost-effectiveness models. Pharmacoeconomics. (2017) 35(Suppl 1):21–31. 10.1007/s40273-017-0545-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-017-0545-x</ArticleId><ArticleId IdType="pubmed">29052157</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. (2005) 60(7):1571–82. 10.1016/j.socscimed.2004.08.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2004.08.034</ArticleId><ArticleId IdType="pubmed">15652688</ArticleId></ArticleIdList></Reference><Reference><Citation>Reenen MV, Janssen B. EQ-5D-5l User Guide. Basic Information on how to Use the EQ-5D-5l Instrument. Rotterdam, the Netherlands: EuroQOL; (2015).</Citation></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5l). Qual Life Res. (2011) 20:1727–36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Szende A, Janssen B, Cabases J. Self-reported Population Health: An International Perspective Based on EQ-5D. Vol. 4. Dordrecht: Springer; (2014). p. 2–6. 10.1007/978-94-007-7596-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-7596-1</ArticleId><ArticleId IdType="pubmed">29787044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong ELY, Xu RH, Cheung AWL. Measurement of health-related quality of life in patients with diabetes mellitus using EQ-5D-5l in Hong Kong, China. Qual Life Res. (2020) 29(7):1913–21. 10.1007/s11136-020-02462-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02462-0</ArticleId><ArticleId IdType="pmc">PMC7295714</ArticleId><ArticleId IdType="pubmed">32140920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong ELY, Xu RH, Cheung AWL. Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5l in Hong Kong SAR, China. Eur J Health Econ. (2020) 21(6):869–79. 10.1007/s10198-020-01178-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-020-01178-9</ArticleId><ArticleId IdType="pubmed">32242296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Guan H, Wang L, Zhang Y, Rui M, Ma A. Health-related quality of life in patients with different diseases measured with the EQ-5D-5l: a systematic review. Front Public Health. (2021) 9(675523):1–23. 10.3389/fpubh.2021.675523</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.675523</ArticleId><ArticleId IdType="pmc">PMC8275935</ArticleId><ArticleId IdType="pubmed">34268287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang R, Janssen MFB, Pickard AS. US population norms for the EQ-5D-5l and comparison of norms from face-to-face and online samples. Qual Life Res. (2021) 30(3):803–16. 10.1007/s11136-020-02650-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02650-y</ArticleId><ArticleId IdType="pmc">PMC7952367</ArticleId><ArticleId IdType="pubmed">33025373</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdin E, Subramaniam M, Vaingankar JA, Luo N, Chong SA. Population norms for the EQ-5D index scores using Singapore preference weights. Qual Life Res. (2015) 24(6):1545–53. 10.1007/s11136-014-0859-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-014-0859-5</ArticleId><ArticleId IdType="pubmed">25394893</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroiwa T, Noto S, Fukuda T. Japanese population norms of EQ-5D-5l and health utilities index mark 3: disutility catalog by disease and symptom in community settings. Value Health. (2021) 24(8):1193–202. 10.1016/j.jval.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2021.03.010</ArticleId><ArticleId IdType="pubmed">34372985</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making. (2011) 31(6):800–4. 10.1177/0272989X11401031</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X11401031</ArticleId><ArticleId IdType="pubmed">21422468</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng G, Hong Y, Luo N, Mukuria C, Jiang J, Yang Z, et al. Comparing EQ-5D-3l and EQ-5D-5l in measuring the HRQoL burden of 4 health conditions in China. Eur J Health Econ. (2023) 24(2):197–207. 10.1007/s10198-022-01465-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-022-01465-7</ArticleId><ArticleId IdType="pubmed">35538178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jyani G, Prinja S, Garg B, Kaur M, Grover S, Sharma A, et al. Health-related quality of life among Indian population: the EQ-5D population norms for India. J Glob Health. (2023) 13:1–2. 10.7189/jogh.13.04018</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.04018</ArticleId><ArticleId IdType="pmc">PMC9936451</ArticleId><ArticleId IdType="pubmed">36799239</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. The EQ-5D-5l valuation study in Egypt. Pharmacoeconomics. (2022) 40(4):433–47. 10.1007/s40273-021-01100-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-021-01100-y</ArticleId><ArticleId IdType="pmc">PMC8595057</ArticleId><ArticleId IdType="pubmed">34786590</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos M, Monteiro AL, Biz AN, Guerra A, Cramer H, Canuto V, et al. Guidelines for utility measurement for economic analysis: the Brazilian policy. Value Health Reg Issues. (2022) 31:67–73. 10.1016/j.vhri.2022.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vhri.2022.03.004</ArticleId><ArticleId IdType="pubmed">35533599</ArticleId></ArticleIdList></Reference><Reference><Citation>Viney R, Norman R, King MT, Cronin P, Street DJ, Knox S, et al. Time trade-off derived EQ-5D weights for Australia. Value Health. (2011) 14(6):928–36. 10.1016/j.jval.2011.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2011.04.009</ArticleId><ArticleId IdType="pubmed">21914515</ArticleId></ArticleIdList></Reference><Reference><Citation>Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. (2015) 33:1137–54. 10.1007/s40273-015-0295-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-015-0295-6</ArticleId><ArticleId IdType="pmc">PMC4609224</ArticleId><ArticleId IdType="pubmed">26040242</ArticleId></ArticleIdList></Reference><Reference><Citation>Welie AG, Gebretekle GB, Stolk E, Mukuria C, Krahn MD, Enquoselassie F, et al. Valuing health state: an EQ-5D-5l value set for Ethiopians. Value Health Reg Issues. (2020) 22:7–14. 10.1016/j.vhri.2019.08.475</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vhri.2019.08.475</ArticleId><ArticleId IdType="pubmed">31683254</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelsma J, Hansen K, De Weerdt W, De Cock P, Kind P. How do Zimbabweans value health states? Popul Health Metr. (2003) 1:1–10. 10.1186/1478-7954-1-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-7954-1-11</ArticleId><ArticleId IdType="pmc">PMC317383</ArticleId><ArticleId IdType="pubmed">14678566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessu S, Girum T, Geremew M, Zeleke B. The burden of disease and cause of mortality in Ethiopia, 2000–2016: findings from the global burden of disease study and global health estimates. Med Stud/Studia Medyczne. (2020) 36(4):246–56. 10.5114/ms.2020.102318</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ms.2020.102318</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay YB, Ali EE, Chung KY, Gebretekle GB, Sander B. Cost-utility analysis of Dolutegravir- vs. Efavirenz-based regimens as a first-line treatment in adult HIV/AIDS patients in Ethiopia. PharmacoEcon Open. (2021) 5(4):655–64. 10.1007/s41669-021-00275-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41669-021-00275-6</ArticleId><ArticleId IdType="pmc">PMC8611130</ArticleId><ArticleId IdType="pubmed">34133017</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US) (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">21433403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer. BMC Med Res Methodol. (2014) 14:1–13. 10.1186/1471-2288-14-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-1</ArticleId><ArticleId IdType="pmc">PMC3932043</ArticleId><ArticleId IdType="pubmed">24383436</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions 5.1 0. Cochrane Collab. (2011) 2011:223–45.</Citation></Reference><Reference><Citation>Gebreyohannes EA, Gebresillassie BM, Mulugeta F, Dessu E, Abebe TB. Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study. Qual Life Res. (2023) 32(11):3269–77. 10.1007/s11136-023-03473-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-023-03473-3</ArticleId><ArticleId IdType="pmc">PMC10522511</ArticleId><ArticleId IdType="pubmed">37405663</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebresillassie BM, Debay YB. Characteristics, treatment, and outcome of patients with hypertensive crisis admitted to university of Gondar specialized hospital, northwest Ethiopia: a cross-sectional study. J Clin Hypertens. (2020) 22(12):2343–53. 10.1111/jch.14056</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.14056</ArticleId><ArticleId IdType="pmc">PMC8029926</ArticleId><ArticleId IdType="pubmed">32966697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebrie MH, Asfaw HM, Bilchut WH, Lindgren H, Wettergren L. Psychometric properties of the kidney disease quality of life-36 (KDQOL-36) in Ethiopian patients undergoing hemodialysis. Health Qual Life Outcomes. (2022) 20(1):24. 10.1186/s12955-022-01932-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-01932-y</ArticleId><ArticleId IdType="pmc">PMC8832803</ArticleId><ArticleId IdType="pubmed">35144625</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimels T, Bogale G, Asrat Kassu R, Gedif T. Quality of life and its predictors among clients visiting antiretroviral therapy clinics in Addis Ababa, Ethiopia. Afr J AIDS Res. (2022) 21(1):15–22. 10.2989/16085906.2021.2013907</Citation><ArticleIdList><ArticleId IdType="doi">10.2989/16085906.2021.2013907</ArticleId><ArticleId IdType="pubmed">35361062</ArticleId></ArticleIdList></Reference><Reference><Citation>Dule A, Hajure M, Mohammedhussein M, Abdu Z. Health-related quality of life among Ethiopian pregnant women during COVID-19 pandemic. Brain Behav. (2021) 11(4):e02045. 10.1002/brb3.2045</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2045</ArticleId><ArticleId IdType="pmc">PMC7994997</ArticleId><ArticleId IdType="pubmed">33506639</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhamed AN, Bogale SK, Netere HB. Quality of life and associated factors among adult cancer patients undergoing chemotherapy treatment at Amhara national, regional state, Ethiopia, 2021. SAGE Open Nurs. (2023) 9:23779608231174866. 10.1177/23779608231174866</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23779608231174866</ArticleId><ArticleId IdType="pmc">PMC10201175</ArticleId><ArticleId IdType="pubmed">37223221</ArticleId></ArticleIdList></Reference><Reference><Citation>Getu MA, Chen C, Wang P, Kantelhardt EJ, Addissie A. Quality of life and its influencing factors among breast cancer patients at Tikur Anbessa specialised hospital, Addis Ababa, Ethiopia. BMC Cancer. (2022) 22(1):897. 10.1186/s12885-022-09921-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-022-09921-6</ArticleId><ArticleId IdType="pmc">PMC9382842</ArticleId><ArticleId IdType="pubmed">35978281</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay YB, Mihalopoulos C, Lee YY, Mulhern B, Engel L. Examining the psychometric properties of a split version of the EQ-5D-5l anxiety/depression dimension in patients with anxiety and/or depression. Qual Life Res. (2023) 32(7):2025–36. 10.1007/s11136-023-03372-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-023-03372-7</ArticleId><ArticleId IdType="pmc">PMC10241678</ArticleId><ArticleId IdType="pubmed">36809437</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay YB, Ali EE, Sander B, Gebretekle GB. Health-related quality of life of patients with HIV/AIDS at a tertiary care teaching hospital in Ethiopia. Health Qual Life Outcomes. (2021) 19(1):1–11. 10.1186/s12955-021-01670-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01670-7</ArticleId><ArticleId IdType="pmc">PMC7816449</ArticleId><ArticleId IdType="pubmed">33468153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebremariam GT, Biratu S, Alemayehu M, Welie AG, Beyene K, Sander B, et al. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia. PLoS One. (2022) 17(2):e0264199. 10.1371/journal.pone.0264199</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264199</ArticleId><ArticleId IdType="pmc">PMC8856533</ArticleId><ArticleId IdType="pubmed">35180266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendekie AK, Dagnew EM, Tefera BB, Belachew EA. Health-related quality of life and its determinants among patients with diabetes mellitus: a multicentre cross-sectional study in northwest Ethiopia. BMJ Open. (2023) 13(1):e068518. 10.1136/bmjopen-2022-068518</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-068518</ArticleId><ArticleId IdType="pmc">PMC9884918</ArticleId><ArticleId IdType="pubmed">36697040</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimels T, Kassu RA, Bogale G, Muleta MB, Akalu GT, Getachew A, et al. Health-related quality of life of patients with type 2 diabetes mellitus and hypertension in Addis Ababa, Ethiopia. Ethiop J Health Sci. (2022) 32(2):1029–857. 10.4314/ejhs.v32i2.19</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ejhs.v32i2.19</ArticleId><ArticleId IdType="pmc">PMC9175229</ArticleId><ArticleId IdType="pubmed">35693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tito K, Gebremariam GT, Beyene K, Sander B, Gebretekle GB. Health-related quality of life and treatment satisfaction of patients with cardiovascular disease in Ethiopia. Front Public Health. (2022) 10:1–15. 10.3389/fpubh.2022.972378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.972378</ArticleId><ArticleId IdType="pmc">PMC9589146</ArticleId><ArticleId IdType="pubmed">36299740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibhat SG, Fenta TG, Sander B, Gebretekle GB. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Health Qual Life Outcomes. (2019) 17(1):165. 10.1186/s12955-019-1239-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-019-1239-1</ArticleId><ArticleId IdType="pmc">PMC6833153</ArticleId><ArticleId IdType="pubmed">31690327</ArticleId></ArticleIdList></Reference><Reference><Citation>Araya LT, Fenta TG, Sander B, Gebremariam GT, Gebretekle GB. Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Health Qual Life Outcomes. (2020) 18(1):72. 10.1186/s12955-020-01319-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01319-x</ArticleId><ArticleId IdType="pmc">PMC7076924</ArticleId><ArticleId IdType="pubmed">32178681</ArticleId></ArticleIdList></Reference><Reference><Citation>Belachew EA, Sendekie AK. Health-related quality of life and its determinants in patients with different dermatological disorders at the university of Gondar comprehensive specialized hospital. BMC Res Notes. (2023) 16(1):191. 10.1186/s13104-023-06442-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-023-06442-8</ArticleId><ArticleId IdType="pmc">PMC10472557</ArticleId><ArticleId IdType="pubmed">37653440</ArticleId></ArticleIdList></Reference><Reference><Citation>Negash Z, Tadiwos A, Urgessa EM, Gebretekle GB, Abebe E, Fentie AM. Insulin injection practice and health related quality of life among individuals with diabetes at Tikur Anbessa specialized hospital, Ethiopia: a cross-sectional study. Health Qual Life Outcomes. (2023) 21(1):38. 10.1186/s12955-023-02123-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-023-02123-z</ArticleId><ArticleId IdType="pmc">PMC10157971</ArticleId><ArticleId IdType="pubmed">37143082</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyar S, Gebremariam GT, Beyene DA, Gebremedhin A, Tadesse TA. Health-related quality of life and its associated factors among hemophilia patients: experience from Ethiopian hemophilia treatment centre. J Pharm Health Care Sci. (2024) 10(1):3. 10.1186/s40780-023-00326-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40780-023-00326-6</ArticleId><ArticleId IdType="pmc">PMC10762823</ArticleId><ArticleId IdType="pubmed">38167221</ArticleId></ArticleIdList></Reference><Reference><Citation>Haftu HK, Hailemariam D, Tassew B, Hagos Gufue Z, Aberhe W. Health-related quality of life using EQ-5D-3l utility score among type 2 diabetes patients: experiences from Tigray Region, Northern Ethiopia. Patient Prefer Adherence. (2022) 16:3143–55. 10.2147/PPA.S324586</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S324586</ArticleId><ArticleId IdType="pmc">PMC9724574</ArticleId><ArticleId IdType="pubmed">36483918</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne AS. Quality of life and associated factors of HIV patients under treatment with first line regimens in public hospitals in Amhara Region, North-West Ethiopia. Patient Prefer Adherence. (2023) 17:1347–59. 10.2147/PPA.S413192</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S413192</ArticleId><ArticleId IdType="pmc">PMC10243354</ArticleId><ArticleId IdType="pubmed">37287512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaso AW, Agero G, Hurisa Z, Kaso T, Ewune HA, Hailu A. Evaluation of health-related quality of life of COVID-19 patients: a hospital-based study in south central Ethiopia. Health Qual Life Outcomes. (2021) 19(1):268. 10.1186/s12955-021-01900-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01900-y</ArticleId><ArticleId IdType="pmc">PMC8685489</ArticleId><ArticleId IdType="pubmed">34930294</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyazewal T, Woldeamanuel Y, Fekadu A, Holland DP, Marconi VC. Effect of digital medication event reminder and monitor-observed therapy vs. standard directly observed therapy on health-related quality of life and catastrophic costs in patients with tuberculosis. JAMA Network Open. (2022) 5(9):e2230509. 10.1001/jamanetworkopen.2022.30509</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.30509</ArticleId><ArticleId IdType="pmc">PMC9478770</ArticleId><ArticleId IdType="pubmed">36107429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaso AW, Tesema HG, Hareru HE, Kaso T, Ashuro Z, Talemahu AA, et al. Health-related quality of life and associated factors among COVID-19 survivors. Experience from Ethiopian treatment centers. Infect Drug Resist. (2022) 15:6143–53. 10.2147/IDR.S386566</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S386566</ArticleId><ArticleId IdType="pmc">PMC9593469</ArticleId><ArticleId IdType="pubmed">36304968</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedini MR, Bijari B, Miri Z, Shakhs Emampour F, Abbasi A. The quality of life of the patients with diabetes type 2 using EQ-5D-5l in Birjand. Health Qual Life Outcomes. (2020) 18:1–9. 10.1186/s12955-020-1277-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-1277-8</ArticleId><ArticleId IdType="pmc">PMC6990543</ArticleId><ArticleId IdType="pubmed">32000785</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson IL, Isah A, Arikpo AO. Assessing health-related quality of life of people with diabetes in Nigeria using the EQ-5D-5l: a cross-sectional study. Sci Rep. (2023) 13(1):22536. 10.1038/s41598-023-49322-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49322-8</ArticleId><ArticleId IdType="pmc">PMC10728144</ArticleId><ArticleId IdType="pubmed">38110447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mafirakureva N, Dzingirai B, Postma MJ, van Hulst M, Khoza S. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe. AIDS Care. (2016) 28(7):904–12. 10.1080/09540121.2016.1173639</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09540121.2016.1173639</ArticleId><ArticleId IdType="pubmed">27098289</ArticleId></ArticleIdList></Reference><Reference><Citation>Anosike C, Anene-Okeke CG, Akunne MO. Assessment of health-related quality of life among patients infected with HIV receiving care in a Nigerian tertiary hospital. Value Health Reg Issues. (2021) 25:1–6. 10.1016/j.vhri.2020.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vhri.2020.09.002</ArticleId><ArticleId IdType="pubmed">33387802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Pandey AK, Dimri K, Jyani G, Goyal A, Prinja S. Health-related quality of life among breast cancer patients in India. Support Care Cancer. (2022) 30(12):9983–90. 10.1007/s00520-022-07395-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-022-07395-7</ArticleId><ArticleId IdType="pubmed">36222977</ArticleId></ArticleIdList></Reference><Reference><Citation>Endarti D, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA. Evaluation of health-related quality of life among patients with cervical cancer in Indonesia. Asian Pac J Cancer Prev. (2015) 16(8):3345–50. 10.7314/APJCP.2015.16.8.3345</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2015.16.8.3345</ArticleId><ArticleId IdType="pubmed">25921142</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual Life Outcomes. (2022) 20(1):125. 10.1186/s12955-022-02033-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-02033-6</ArticleId><ArticleId IdType="pmc">PMC9388960</ArticleId><ArticleId IdType="pubmed">35986269</ArticleId></ArticleIdList></Reference><Reference><Citation>Amedewonu EA, Aryeetey GC, Godi A, Sackeyfio J, Dai-Kosi AD. Assessment of the quality of life of COVID-19 recovered patients at the Ghana infectious disease centre. PLoS One. (2024) 19(7):e0306118. 10.1371/journal.pone.0306118</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0306118</ArticleId><ArticleId IdType="pmc">PMC11257348</ArticleId><ArticleId IdType="pubmed">39024249</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel AN, Zhu S, Cooper N, Roderick P, Alwan N, Tarrant C, et al. Impact of COVID-19 on health-related quality of life of patients: a structured review. PLoS One. (2021) 16(10):e0259164. 10.1371/journal.pone.0259164</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MAS, Dalal K, Hasan M, Haque MMA, Nusrat EM, Hossian M, et al. The impact of comorbidity on the quality of life of people who recovered from COVID-19 in Bangladesh. IJID Reg. (2024) 11(100351):1–7. 10.1016/j.ijregi.2024.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2024.03.006</ArticleId><ArticleId IdType="pmc">PMC11021361</ArticleId><ArticleId IdType="pubmed">38634072</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. (2020) 11(5):296–302. 10.24171/j.phrp.2020.11.5.05</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2020.11.5.05</ArticleId><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L, Mazzoli CA, Sintonen H, Colombo D, Scaramuzzo G, Allegri D, et al. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up. Qual Life Res. (2021) 30(10):2805–17. 10.1007/s11136-021-02865-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02865-7</ArticleId><ArticleId IdType="pmc">PMC8113006</ArticleId><ArticleId IdType="pubmed">33977415</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for: 291, diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study. Lancet. (2010) 2013:125–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">23245608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. (1994) 330(9):592–6. 10.1056/NEJM199403033300902</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300902</ArticleId><ArticleId IdType="pubmed">7508092</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer AJ, Campbell JA, de Graaff B, Devlin N, Ahmad H, Clarke PM, et al. Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia. Health Econ. (2021) 30(8):1950–77. 10.1002/hec.4281</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.4281</ArticleId><ArticleId IdType="pubmed">34018630</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy LM, Neill A, Swampy K, Auger J, Campbell SM, Chatwood S, et al. Preference-based measures of health-related quality of life in indigenous people: a systematic review. Qual Life Res. (2024) 33(2):317–33. 10.1007/s11136-023-03499-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-023-03499-7</ArticleId><ArticleId IdType="pmc">PMC10850204</ArticleId><ArticleId IdType="pubmed">37715878</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>